Literature DB >> 8261303

Proliferation indices as independent prognostic factors in papillary Ta-T1 transitional cell bladder tumours.

P K Lipponen1, M J Eskelinen, K Jauhiainen, R Terho, S Nordling.   

Abstract

A cohort of 148 patients with papillary Ta-T1 transitional cell carcinomas (TCCs) was followed up for over 10 years and flow cytometric (DNA ploidy, S phase fraction) and morphometric variables (5 nuclear factors, volume corrected mitotic index) were related to prognosis during this period. Recurrence-free survival was significantly related to DNA ploidy, S phase fraction and M/V index. Progression in T-category was predicted by M/V index, S phase fraction, DNA ploidy and WHO grade. The same variables predicted progression in N- and M-categories. In a multivariate analysis only M/V index and S phase fraction were independent predictors of progression. Univariate analysis showed that M/V index, SPF, DNA ploidy and WHO grade predicted survival. In a multivariate survival analysis only M/V index and SPF were independent predictors. The results showed that proliferation indices had independent prognostic value in papillary Ta-T1 TCCs and the grading of these tumours could be based on the proliferation indices. Papillary Ta-T1 tumours with a M/V index value < or = 10/mm2 or SPF < or = 10% had a favourable prognosis whereas tumours with M/V index > 10/mm2 or SPF > 10% had a high malignant potential.

Entities:  

Mesh:

Year:  1993        PMID: 8261303     DOI: 10.1111/j.1464-410x.1993.tb16176.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  2 in total

1.  The prognostic value of proliferating cell nuclear antigen, Ki-67 and nucleolar organizer region in transitional cell carcinoma of the bladder.

Authors:  Murat Bozlu; Diclehan Orhan; Sümer Baltaci; Onder Yaman; Atilla Halil Elhan; Ozden Tulunay; Yusuf Ziya Müftüoğlu
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer.

Authors:  P K Lipponen; M J Eskelinen
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.